Skip to main content
Boston Employee homeNews home
Story

Novo’s CEO Turns to Next Targets After Losing Metsera to Pfizer - Bloomberg.com

Novo’s CEO Turns to Next Targets After Losing Metsera to Pfizer  Bloomberg.com Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits  Reuters Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk  Yahoo Finance Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal  The New York Times Metsera accepts Pfizer's $10B takeout offer, passing over Novo  FirstWord Pharma

Latest News